Korsana Biosciences, Inc.(KRSA)

Biotechnology · Waltham, MA

$31.34+0.62 (+2.02%)

Delayed quote: Oct 6, 2026, 10:09 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T14:12:38.264Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:12:38.264Z.

Quote observation: 2026-10-06T14:09:13.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -6,824,000
Quote market capitalization: 146,713,509
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 1,391,000

FMP input reference: a391670e5a4a022aad0cee8204cefb21b4613c0a4e77d467850b61b24c11a6b7

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

KRSA EBITDA Yield Metrics

EBITDA YIELD

N/A

KRSA Competitors' EBITDA Yield

KRSA

Korsana Biosciences, Inc.

Current

Market Cap

$146.71M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABOS

Acumen Pharmaceuticals, Inc.

vs KRSA

Market Cap

$148.07M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMRX

Immuneering Corporation

vs KRSA

Market Cap

$144.79M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFMDP

LifeMD, Inc.

vs KRSA

Market Cap

$142.72M

EBITDA Yield

N/A

TTM Avg

0.81%

3Y Avg

0.81%

5Y Avg

0.81%

CRDL

Cardiol Therapeutics Inc.

vs KRSA

Market Cap

$151.58M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBIOP

Fortress Biotech, Inc.

vs KRSA

Market Cap

$141.70M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs KRSA

Market Cap

$152.74M

EBITDA Yield

N/A

TTM Avg

1.29%

3Y Avg

1.28%

5Y Avg

1.28%

ACOG

Alpha Cognition Inc

vs KRSA

Market Cap

$140.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs KRSA

Market Cap

$139.95M

EBITDA Yield

0.22%

TTM Avg

0.33%

3Y Avg

3.24%

5Y Avg

2.95%

FRNM

Freenome, Inc.

vs KRSA

Market Cap

$138.47M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Korsana Biosciences, Inc. (KRSA)	$146.71M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$148.07M	N/A	N/A	N/A	N/A
Immuneering Corporation (IMRX)vs ›	$144.79M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMDP)vs ›	$142.72M	N/A	0.81%	0.81%	0.81%
Cardiol Therapeutics Inc. (CRDL)vs ›	$151.58M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIOP)vs ›	$141.70M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$152.74M	N/A	1.29%	1.28%	1.28%
Alpha Cognition Inc (ACOG)vs ›	$140.09M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$139.95M	0.22%	0.33%	3.24%	2.95%
Freenome, Inc. (FRNM)vs ›	$138.47M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

KRSA EBITDA Yield Metrics

KRSA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics